iSpecimen
iSpecimen operates a Nasdaq-listed (ISPC) two-sided online marketplace for human biospecimens, connecting pharma, biotech, IVD, and academic researchers with 250+ global healthcare provider suppliers. The platform offers AI-driven inventory matching, pre-screened tumor tissue, and prospective collection services.
- Company typePublic
- Founded2014
- HeadquartersLexington, United States
- Headcount51–100
- GTM typeB2B
- OfferingDigital Commerce or Content
What iSpecimen does
iSpecimen (Nasdaq: ISPC) operates an online two-sided marketplace for human biospecimens, connecting life sciences researchers in pharmaceutical, biotechnology, in vitro diagnostics (IVD), and academic organizations with a global network of 250+ healthcare provider suppliers. The platform, headquartered in Woburn, Massachusetts, is built on AWS and offers pre-screened, mutation-characterized DNA/RNA-sequenced tumor tissue, fresh and preserved biofluids, IVD validation kits, and services for matched sets and prospective collections. Automated de-identification, HIPAA / GDPR / 45 CFR 46 / IRB / IEC compliance, and a Preferred Provider of Cancer Biospecimens designation anchor its regulatory positioning.
iSpecimen firmographics
Firmographics- Name
- iSpecimen
- Legal name
- iSpecimen Inc.
- Website
- https://ispecimen.com
- Company type
- Public
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- iSpecimen operates a Nasdaq-listed (ISPC) two-sided online marketplace for human biospecimens, connecting pharma, biotech, IVD, and academic researchers with 250+ global healthcare provider suppliers. The platform offers AI-driven inventory matching, pre-screened tumor tissue, and prospective collection services.
- Ownership category
- akta.pro rank
iSpecimen industry classification
Industry- Product category
- Biospecimen Marketplace
- NAICS
- Scientific Research and Development Services (5417), Medical and Diagnostic Laboratories (6215), Testing Laboratories and Services (541380)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO)
- akta.pro secondary industries
- Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB), Clinical Trial Supply, Logistics & Vendor Management FSP (HLAGAOAH), Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA), Cell-Based & Potency Assays (Bioassays) (HLAGADAH)
Keywords
Where iSpecimen is headquartered
LocationHeadquarters
- HQ city
- Lexington
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
iSpecimen business model
Business model- GTM type
- B2B
- Offering type
- Digital Commerce or Content
- Cost components
- Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations, Others
Revenue model
- Marketplace transaction fees on biospecimen sales: iSpecimen generates revenue by taking a margin/commission on biospecimen transactions facilitated through the iSpecimen Marketplace® between researcher buyers and healthcare provider suppliers. Healthcare providers receive a sustainable revenue stream from remnant, banked, or prospectively collected samples sold via the platform.
- Custom specimen procurement and project services: Revenue from custom specimen procurement, prospective collection projects, study design services, sample kitting and logistics, lab services, and biospecimen data management for researchers whose needs exceed off-the-shelf banked inventory. Includes project-based fees for matched-set, liquid biopsy, and rare-disease cohort builds.
- IVD validation testing kit sales: Revenue from customizable, launch-ready validation testing kits containing clinically-characterized samples or diagnostic reference specimens sold to in-vitro diagnostics (IVD) companies to support onboarding of new diagnostic tests and instrument systems.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | — | Quote-based pricing for all biospecimens and services; no public price list |
| Other | — | Custom discounts for large or repeat orders |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels8 records
iSpecimen product offering
Product offeringCore offering
iSpecimen operates an online global marketplace that connects life science researchers with a network of 250+ healthcare provider organizations to procure human biospecimens (biofluids, tissue, and cells) for research, drug discovery, and diagnostic test validation. The company takes a margin on each marketplace transaction, provides custom and prospective specimen procurement services, and sells ready-to-use validation testing kits for IVD companies. All transactions are processed under a unified contract with integrated compliance (HIPAA, GDPR, IRB/IEC).
Product overview
iSpecimen operates a single integrated platform-plus-modules architecture anchored on the iSpecimen Marketplace, an Amazon-like online global marketplace that connects life science researchers needing human biospecimens with a network of healthcare providers and biorepositories. The Marketplace is powered by the SalesStack digital transformation platform, which delivered end-to-end system integration, legacy data migration, and live production activation in its Milestone 2, and which embeds AI-driven matching capabilities including the internally developed AI-powered Inventory Agent (an LLM-powered conversational agent that extracts request criteria and ranks inventory matches). On top of the core marketplace, iSpecimen sells sub-product specimen categories — Human Biofluids (whole blood, serum & plasma, buffy coats, swabs, urine, stool, CSF, saliva, sputum), Human Tissue Samples (fresh, fresh frozen, FFPE, tissue microarrays, DNA & RNA sequenced cancer tissue, matched sets), Stem and Immune Cells (leukopaks, mobilized leukopaks, bone marrow aspirate, PBMCs, BMMCs), Validation Testing Kits (IVD), and Matched Biospecimen Sets — supported by service offerings (Specimen Procurement, Study Design, Sample Kits and Logistics, Biospecimen Data & Data Management, Lab Services), partner-facing programs such as the Marketplace Onsite Program, and operational enhancements such as the Open Feasibilities Dashboard and the Direct Shipping Model. Together, these products, sub-categories, and services compose a unified biospecimen procurement ecosystem with AI-augmented matching and a single contracting interface across hundreds of supplier organizations.
Differentiator
Problem solved
Functional benefit
Brands
- iSpecimen Marketplace: The company's flagship online marketplace platform (registered as iSpecimen Marketplace®) that connects life science researchers with healthcare biospecimen providers for streamlined procurement of human biospecimens.
- SalesStack
- Inventory Agent
Products and services
- iSpecimen Marketplace
- Human Biofluids
- Human Tissue Samples
- Stem and Immune Cells
- Matched Biospecimen Sets
- Validation Testing Kits (IVD)
- DNA and RNA Sequenced Cancer Tissue
- Specimen Procurement Services
- Study Design Services
- Sample Kits and Logistics
- Biospecimen Data and Data Management
- Lab Services
- Marketplace Onsite Program
- Direct Shipping Model
Quantifiable outcome
- Over 80% of researchers report limiting studies due to insufficient biospecimen quantities — iSpecimen's marketplace addresses this access gap.
- +6 more outcomes
Companies that use iSpecimen
Customer profileNamed customers4 records
Segments6 records
Ideal customer profiles5 records
iSpecimen technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature6 records
iSpecimen partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered major blood-center alliance, technology integration partner, marketplace partner, industry association partner, regional biotech industry partner and trade media partner.
- OneBloodmajor blood-center allianceListed on iSpecimen's Industry Alliances page as a partner, indicating a relationship with the major U.S. blood center to support blood-product biospecimen supply through the iSpecimen Marketplace.
- Agilent (Agilent SLIMS)technology integration partnerAgilent's SLIMS laboratory information management system is referenced as an Industry Alliance partner, supporting integration between biospecimen provider labs and the iSpecimen Marketplace platform.
- Science Exchangemarketplace partnerScience Exchange listed as an Industry Alliance partner, extending iSpecimen's reach into a broader outsourced research services marketplace.
- Scientist.commarketplace partnerScientist.com listed as an Industry Alliance partner, connecting iSpecimen's biospecimen supply with Scientist.com's research-services procurement platform.
- Association of Clinical Research Professionals (ACRP)industry association partnerListed as an Industry Alliance partner supporting clinical research professional education and biospecimen sourcing awareness.
- Pathology Informatics (pathologyinformatics.org)industry association partnerListed as an Industry Alliance partner supporting pathology informatics standards relevant to biospecimen data management.
- International Society for Biological and Environmental Repositories (ISBER)industry association partnerListed as an Industry Alliance partner; iSpecimen presented new research at the ISBER 2022 Annual Meeting in Atlanta.
- MassBio (Massachusetts Biotechnology Council)regional biotech industry partnerListed as an Industry Alliance partner supporting the Massachusetts biotech ecosystem.
- The Dark Intelligence Group / The Dark Reporttrade media partnerListed as an Industry Alliance partner, providing exposure in the clinical laboratory and blood-banking trade media space.
Scale indicators13 records
Recent moves9 records
Expansion highlights6 records
iSpecimen competitors and assessment
Company assessmentDirect peers
- BioIVT: Global supplier of human biospecimens (including acquired Tissue Solutions) serving pharma, biotech, diagnostics, and academic researchers with a multi-supplier network. Directly comparable as a competing biospecimen procurement marketplace and catalog.
- Discovery Life Sciences: Biospecimen procurement and sample management services company offering characterized biospecimens, custom collections, and biobanking across multiple disease states. Competes directly with iSpecimen's marketplace in pharma and biotech accounts.
- Cureline: Clinical biospecimen CRO with biorepository and prospective collection capabilities spanning oncology, infectious disease, and women's health. Closely comparable in customer base (pharma/biotech) and biospecimen procurement service model.
- ProteoGenex: Biospecimen supplier specializing in human tissue samples including FFPE, frozen, and fresh tissue with annotated clinical data. Comparable in tissue-focused biospecimen offerings to pharma and academic oncology researchers.
- BioChain Institute: Provider of tissue and biofluid biospecimens, RNA/DNA extracted products, and tissue microarrays. Comparable in catalog tissue and biospecimen offerings targeting pharma and academic research customers.
Broad incumbents
- Lonza: Global life sciences manufacturer with a large bioscience segment offering primary cells, hematopoietic products, and biospecimens. Overlaps with iSpecimen's stem and immune cell offerings and serves similar pharma/biotech customers as part of a much broader portfolio.
- Charles River Laboratories: Major CRO offering biospecimen and research services alongside preclinical and clinical offerings. Competes for pharma biospecimen procurement budgets as part of a much wider services portfolio.
- ATCC: Non-profit biological resource center providing authenticated cell lines, microbial materials, and biospecimens. Comparable as a supplier of characterized research specimens to academic and biopharma customers, though focused on catalog rather than prospective collections.
Emerging players
- Stemcell Technologies: Specialty provider of cell culture media, cell separation products, and primary cells (PBMCs, hematopoietic products). Comparable in stem and immune cell product lines that overlap with iSpecimen's hematologic specimen offerings.
Others
- Scientist.com: Outsourced research services marketplace connecting biopharma researchers with service providers. Listed as an iSpecimen Industry Alliance partner and is adjacent in the research procurement marketplace category.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
iSpecimen social profiles
Digital presenceiSpecimen compliance and trust
Trust signalCompliance3 records
iSpecimen financial estimates
Financial estimateRevenue estimate
Valuation estimate
iSpecimen leadership team
Management profileNumber of profiles
Profiles7 records
iSpecimen funding detail
Funding detailFunding overview
Funding rounds9 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
iSpecimen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about iSpecimen
What does iSpecimen do?
iSpecimen operates an online global marketplace that connects life science researchers with a network of 250+ healthcare provider organizations to procure human biospecimens (biofluids, tissue, and cells) for research, drug discovery, and diagnostic test validation. The company takes a margin on each marketplace transaction, provides custom and prospective specimen procurement services, and sells ready-to-use validation testing kits for IVD companies. All transactions are processed under a unified contract with integrated compliance (HIPAA, GDPR, IRB/IEC).
Is iSpecimen a public or private company?
iSpecimen is a public company. It is classified as public and is currently operating.
When was iSpecimen founded?
iSpecimen was founded in 2014. It employs 51 to 100 people.
Where is iSpecimen based?
iSpecimen is headquartered in Lexington, United States, in the North America region.
How does iSpecimen make money?
Three revenue lines are on record. Marketplace transaction fees on biospecimen sales are the primary driver. The others are custom specimen procurement and project services and IVD validation testing kit sales.
Who are iSpecimen's main competitors?
Direct peers on record are BioIVT, Discovery Life Sciences, Cureline, ProteoGenex and BioChain Institute. Broad incumbents are Lonza, Charles River Laboratories and ATCC. Stemcell Technologies is listed as an emerging player. Scientist.com is listed as an others.
Does iSpecimen have an API?
No public API is recorded for iSpecimen.
What industry is iSpecimen in?
iSpecimen's product category is Biospecimen Marketplace. Its primary akta.pro industry code is HLACAOAO, Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines), with a secondary code of HLAGAOAB, Data Management, Biostatistics & Statistical Programming FSP. Its NAICS code is 5417 and its SIC code is 8731.